Contact: William Davis
University of North Carolina Health Care
Caption: The study, published Sept. 24 in Lancet Oncology, was led by Ethan Basch, M.D., director of the Cancer Outcomes Research Program at the University of North Carolina Lineberger Comprehensive Cancer Center.
Credit: UNC Lineberger Comprehensive Cancer Center
Usage Restrictions: None
Related news release: Abiraterone acetate delays quality of life decline in men with metastatic prostate cancer